S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

Detalles Bibliográficos
Autores principales: Grassmann, S, Peters, P, Zeng, Y, Schmollinger, J, Endres, S, Kobold, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Invited Speaker Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072111/
http://dx.doi.org/10.1186/2051-1426-2-S2-I19
_version_ 1782322906562297856
author Grassmann, S
Peters, P
Zeng, Y
Schmollinger, J
Endres, S
Kobold, S
author_facet Grassmann, S
Peters, P
Zeng, Y
Schmollinger, J
Endres, S
Kobold, S
author_sort Grassmann, S
collection PubMed
description
format Online
Article
Text
id pubmed-4072111
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721112014-06-27 S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy Grassmann, S Peters, P Zeng, Y Schmollinger, J Endres, S Kobold, S J Immunother Cancer Invited Speaker Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072111/ http://dx.doi.org/10.1186/2051-1426-2-S2-I19 Text en Copyright © 2014 Grassmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Invited Speaker Presentation
Grassmann, S
Peters, P
Zeng, Y
Schmollinger, J
Endres, S
Kobold, S
S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
title S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
title_full S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
title_fullStr S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
title_full_unstemmed S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
title_short S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
title_sort s81. proffered paper: a new pd1-cd28 chimeric receptor overcomes pd-1-mediated immunosuppression in adoptive t cell therapy
topic Invited Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072111/
http://dx.doi.org/10.1186/2051-1426-2-S2-I19
work_keys_str_mv AT grassmanns s81profferedpaperanewpd1cd28chimericreceptorovercomespd1mediatedimmunosuppressioninadoptivetcelltherapy
AT petersp s81profferedpaperanewpd1cd28chimericreceptorovercomespd1mediatedimmunosuppressioninadoptivetcelltherapy
AT zengy s81profferedpaperanewpd1cd28chimericreceptorovercomespd1mediatedimmunosuppressioninadoptivetcelltherapy
AT schmollingerj s81profferedpaperanewpd1cd28chimericreceptorovercomespd1mediatedimmunosuppressioninadoptivetcelltherapy
AT endress s81profferedpaperanewpd1cd28chimericreceptorovercomespd1mediatedimmunosuppressioninadoptivetcelltherapy
AT kobolds s81profferedpaperanewpd1cd28chimericreceptorovercomespd1mediatedimmunosuppressioninadoptivetcelltherapy

Ejemplares similares